SCLXW — Scilex Holding Co
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1820190 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 7,642,000 | 3,965,000 | -29,423,000 | -113,500,000 | 253,562,000 | 566,000 | 564,050,000 |
| Mar 2026 | 8,613,000 | 4,166,000 | -32,169,000 | -43,270,000 | 293,635,000 | 3,351,000 | 547,705,000 |
| Dec 2025 | 4,793,000 | 2,179,000 | -37,482,000 | -33,112,000 | 364,981,000 | 4,955,000 | 576,734,000 |
| Sep 2025 | 10,560,000 | 7,231,000 | -186,512,000 | -257,234,000 | 275,879,000 | 878,000 | 455,598,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-93,357,000
Investing CF
$42,612,000
Financing CF
$-3,744,000
CapEx
$-3,633,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,078,556,000
Inventory
$4,171,000
Receivables
$25,639,000
ST Investments
$15,000
EBIT TTM
$-438,666,000
Pretax Income TTM
$-464,547,000
Interest Exp TTM
$15,082,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$31,608,000
EBITDA
$-277,268,000
Free Cash Flow
$-8,842,550
Enterprise Value
—
Total Cash
$581,000
Total Debt
$105,985,000
Shares Out
—
Trailing EPS
—
Book Value
$-43.83
ROE
—
ROA
-105.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 30,253,000 | -272,304,000 | -358,734,000 | 364,981,000 | 576,734,000 | -207,782,000 | 3,816,000 |
| Dec 2024 | 56,590,000 | -92,787,000 | -72,807,000 | 92,953,000 | 285,596,000 | -192,643,000 | 19,349,000 |
| Dec 2023 | 46,743,000 | -105,431,000 | -114,331,000 | 101,309,000 | 274,247,000 | -172,938,000 | -20,707,000 |
| Dec 2022 | 38,034,000 | -50,634,000 | -23,364,000 | 86,527,000 | 50,288,000 | 36,239,000 | -21,258,000 |
TTM Snapshot
Revenues TTM
$31,608,000
NetIncome TTM
$-464,561,000
OpCashFlow TTM
—
Assets (Latest)
$253,562,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $247.70B | $457.93 | — |
| GILD | GILEAD SCIENCES, INC. | $211.18B | $170.26 | — |
| MRNA | Moderna, Inc. | $82.56B | $206.80 | — |
| ARGX | ARGENX SE | $58.92B | $947.52 | — |
| BIIB | BIOGEN INC. | $37.07B | $250.79 | — |
News headlines (Yahoo Finance, 1h cache)
Datavault AI Stock Jumps 31% Even as Its Bitcoin Sits Stuck at Biconomy
2026-10-28 23:35 · Yahoo
Bitcoin Treasury Datavault AI Says It Can’t Access Its BTC, Stock Tanks
2026-10-28 21:46 · Yahoo
$150 Million Bitcoin Controversy Crashes a Nasdaq Stock
2026-10-28 15:41 · Yahoo
Datavault AI Says It Can’t Access Its Bitcoin Holdings
2026-10-28 13:10 · Yahoo
Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.
2026-08-20 20:12 · Yahoo
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Inv
2026-07-07 10:00 · Yahoo
Scilex, Vera Therapeutics rise premarket; Strategy gains
2026-07-06 12:19 · Yahoo
Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)
2026-07-06 11:33 · Yahoo
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
2026-07-06 10:00 · Yahoo
ZTlido Emerges as Top Non-Opioid Pain Therapy: Market Expansion and Physician Adoption Insights
2026-07-03 09:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.